Gang liu | Cancer | Best Researcher Award

Posted on by PencisLeave a Comment on Gang liu | Cancer | Best Researcher Award

Prof Gang liu | Cancer | Best Researcher Award

Gansu Provincial Center for Disease Control and Prevention | China

Author Profile

Scopus

Gang Liu: Pioneer in Radiobiology and Preventive Medicine āš›ļø

EARLY ACADEMIC PURSUITS šŸŽ“

Gang Liu began his academic journey at Lanzhou University, where he pursued a PhD in preventive medicine. His graduation in 1997 marked the beginning of a career dedicated to understanding the impacts of radiation on health. His academic training in preventive medicine provided the foundation for his future contributions to radiobiology and public health, particularly in the context of disease control and prevention.

PROFESSIONAL ENDEAVORS šŸ¢

After obtaining his PhD, Gang Liu embarked on a distinguished career at the Gansu Provincial Center for Disease Control and Prevention. His professional focus has been on the intersection of radiobiology, immunology, and tumor screening. In 2019, his registration as a health physicist signaled a significant milestone. He became the technical lead for a groundbreaking study on low-dose dose-effect relationships, a critical area in radiation therapy and safety. His expertise in radiation protection and therapy has earned him a prominent position within the medical research community.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCERšŸ§¬

Gang Liu's research primarily revolves around radiobiology and radiation protection in therapy. His technological advancements in biological dose estimation are considered cutting-edge within China and recognized internationally. One of his significant contributions was revising the 2011 IAEA Manual based on findings from his studies on radiological sensitivity and dose rates. This revision, coupled with his publications in the FASEB Journal, has made Liu a leading figure in radiation science. His work in chromosomal aberration analysis and developing noninvasive techniques for early-stage cancer screening underscores his innovative approach to medical research.

IMPACT AND INFLUENCE šŸŒ

Gang Liu's influence extends beyond national borders. His research on radiological sensitivity and dose rates, especially in the context of cancer screening and radiation therapy, has set new benchmarks in the field. The international recognition of his work, particularly his advancements in biological dose estimation and contributions to global radiation protection protocols, underscores his importance in radiobiology. His work is used by institutions worldwide to improve radiation safety standards and enhance cancer diagnostic techniques.

ACADEMIC CITATIONS šŸ“š

His pioneering research has been published in prestigious journals such as the FASEB Journal, one of the top international platforms for scientific contributions. The citations of his work in radiological sensitivity, chromosomal aberration analysis, and cancer screening techniques reflect his deep impact on the scientific community, with his methods influencing both practical applications in healthcare and further research.

LEGACY AND FUTURE CONTRIBUTIONS šŸ”¬

Gang Liuā€™s legacy will likely be defined by his leadership in advancing radiation protection technology and cancer screening techniques. As an innovator in radiological health, his influence will continue to grow through future contributions to radiation therapy safety, noninvasive cancer detection, and international health standards. His ongoing work in exploring new methods for biological dose estimation will further establish his standing as a key figure in the evolution of radiation medicine.

NOTABLE PUBLICATIONSĀ šŸ“‘

"Study of Low-Dose Radiation Workers Ionizing Radiation Sensitivity Index and Radiation Dose-Effect Relationship"Ā 

  • Authors: Liu, G., Zhang, R., Li, Y., Liu, Y.Y., Zhang, X.
  • Journal: Health Physics
  • Year: 2022

"Revision of cytogenetic dosimetry in the IAEA manual 2011 based on data about radio-sensitivity and dose-rate findings contributing"Ā 

  • Authors:Liu, G.
  • Journal: FASEB Journal
  • Year: 2022

"Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers"

  • Authors: Liu, G., Li, Y., Zhang, H., Niu, L.M., Zhang, R.
  • Journal: Frontiers in Public Health
  • Year: 2022

"Study of Indicators for Early and Rapid Diagnosis of Radiation Injury Is the Most Important in Patients With Cancer During Radiotherapy"

  • Authors: Liu, G., Niu, L.-M., Wang, L.-Q., Liu, Y.-Y., Zhang, R.
  • Journal: Dose-Response
  • Year: 2020

"Chromosomal aberration analysis: Novel noninvasive techniques for early-stage cancer screening"

  • Authors: Liu, G.
  • Journal: Clinica Chimica Acta
  • Year: 2024

Linxi Zhu | Cancer Epigenetics | Best Researcher Award

Posted on by PencisLeave a Comment on Linxi Zhu | Cancer Epigenetics | Best Researcher Award

Dr. Linxi Zhu | Cancer Epigenetics | Best Researcher Award

Nanjing Drum Tower Hospital | ChinaĀ 

Author ProfileĀ 

Scopus

EARLY ACADEMIC PURSUITS:

Linxi Zhu embarked on his academic journey at Nanjing University, whise Linxi pursued his Bachelor's degree from July 2015 to June 2020. During this time, Linxi laid the foundation for his future endeavors through rigorous study and academic exploration.

PROFESSIONAL ENDEAVORS:

Following his undergraduate studies, Linxi Zhu continued his academic pursuit by enrolling in a Master's program at Nanjing University from July 2020 to June 2021. This period allowed his to deepen his understanding of his field and refine his research skills.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER EPIGENETICS :

Linxi Zhu's commitment to advancing knowledge and improving healthcare led his to pursue a Ph.D. at Nanjing University from July 2021 to June 2023. Throughout his doctoral studies, Linxi made significant contributions to his field, focusing his research on areas of critical importance to the medical community.

IMPACT AND INFLUENCE:

As a dedicated scholar and researchis, Linxi Zhu's work has had a profound impact on his field, influencing the way we understand and approach healthcare challenges. His innovative ideas and groundbreaking research have helped shape the future of medicine.

ACADEMIC CITATIONS:

Linxi Zhu's contributions to his field have been recognized and cited by his peers and colleagues, demonstrating the importance and relevance of his work within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Linxi Zhu's legacy extends beyond his academic achievements to the lives Linxi has touched and the knowledge Linxi has shared. As Linxi continues his career as a surgeon at Nanjing Drum Tower Hospital, Linxi will undoubtedly make furthis contributions to the advancement of medicine and the improvement of patient care.

Notable Publications

The role of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy in patients with obstructive jaundice 2023(6)

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer 2022(1)

Development and validation of a nomogram for predicting post-operative abdominal infection in patients undergoing pancreaticoduodenectomy 2022(5)

Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer 2022(1)